Percutaneous coronary intervention: Difference between revisions
No edit summary |
No edit summary |
||
Line 23: | Line 23: | ||
==[[Post PCI medical management of the interventional patient|Post-PCI Management]]== | ==[[Post PCI medical management of the interventional patient|Post-PCI Management]]== | ||
==PCI Complications== | |||
[[Coronary artery perforation|Vessel Perforation]] | [[Coronary artery dissection classification|Dissection]] | [[PCI Complications: Distal Embolization|Distal Embolization]] | [[PCI Complications: "No-Reflow"|No-reflow]] | [[PCI Complications: Abrupt Closure|Abrupt Closure]] | [[Access site complications|Access Site Complications]] | [[PCI Complications: Peri-procedure Bleeding|Peri-procedure Bleeding]] | [[PCI Complications: Restenosis|Restenosis]] | [[PCI Complications: Renal Failure|Renal Failure]] | [[PCI Complications: Thrombocytopenia|Thrombocytopenia]] | [[Late aquired stent malapposition|Late Acquired Stent Malapposition]] |
Revision as of 15:56, 26 October 2012
Percutaneous coronary intervention Microchapters |
PCI Complications |
---|
PCI in Specific Patients |
PCI in Specific Lesion Types |
Percutaneous coronary intervention On the Web |
American Roentgen Ray Society Images of Percutaneous coronary intervention |
Directions to Hospitals Treating Percutaneous coronary intervention |
Risk calculators and risk factors for Percutaneous coronary intervention |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: PCI; balloon angioplasty; percutaneous transluminal angioplasty
Overview
Risk Stratification and Benefits of PCI
PCI Guidelines
Preparation of the Patient for PCI
Equipment Used During PCI
Pharmacotherapy to Support PCI
Vascular Closure Devices
Post-PCI Management
PCI Complications
Vessel Perforation | Dissection | Distal Embolization | No-reflow | Abrupt Closure | Access Site Complications | Peri-procedure Bleeding | Restenosis | Renal Failure | Thrombocytopenia | Late Acquired Stent Malapposition